申请人:UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
公开号:US20150238439A1
公开(公告)日:2015-08-27
Some aspects of the invention include attenuating DNMT1 inhibitor activity in an animal comprising administering an antioxidant. Other aspects of the invention include methods comprising administering a composition comprising a DNMT1 inhibitor and an antioxidant. In some instances in the methods, the animal is undergoing a treatment for cancer. Additional aspects of the invention include compositions comprising a DNMT1 inhibitor and an antioxidant.